Loading clinical trials...
Loading clinical trials...
This is a multi-center, Phase I study of a new investigational drug, VTX-2337, that may stimulate the immune system to help fight cancer. The purpose of the study is to assess the safety of the invest...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Celgene
NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more
NCT07589530 · Advanced Solid Tumors, Metastatic Solid Tumors, and more
NCT07042100 · Advanced Solid Tumors
NCT06659341 · Advanced Solid Tumors Harboring KRAS G12C Mutation
NCT05100862 · Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma
Mayo Clinic
Scottsdale, Arizona
Scottsdale Healthcare
Scottsdale, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions